AzTrials
AzTrials

Psychosocial ProblemNCT07644091

Psychosocial Burden and Quality of Life in Caretakers of Hepatobiliary Cancer Patients

An observational study of Psychosocial Problem, run by Methodist Health System at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Assess caregiver psychosocial burden, including Quality of Life, health, interpersonal relationship, access to support, and explore associated sociodemographic and contextual factors. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Psychosocial Problem
How many people
150 participants
Where
1 siteUnited States
Study dates
26 May 2026to May 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Systemic assessment of caregiver needs and outcomes remains limited, and support services are inconsistently utilized or inadequately tailored to this population. Addressing this gap is critical, as caregiver well-being has downstream effects on patient outcomes, care continuity, and family resilience. By quantitatively characterizing the psychosocial burden, unmet needs, and support utilization among caregivers of patients with pancreatic and other major cancer types, this study aims to capture a more comprehensive understanding of the caregiving experience across the cancer continuum. The findings will provide an essential evidence base to inform targeted interventions aimed at improving both caregiver and patient Quality of Life.

Who may be able to join

  • Caretakers must be aged 18 years or older at the time of the survey Participants must be a family member or caretaker of an individual who is diagnosed with hepatobiliary cancer and is receiving care at the Methodist Cancer Center in Richardson, Texas. Diagnosis should be made within 2 years and is non-recurrent in nature. Participants must be an English speaker.

Who cannot join

  • This study is intended to assess the burden and well-being of unpaid caretakers of hepatobiliary cancer patients. Thus, paid caretakers, such as home health aides, will be excluded from the survey.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Crystee Cooper, DHEd contact

214-947-1280

ClinicalResearch@mhd.com

Kavya Mankulangara contact

214-947-4604

ClinicalResearch@mhd.com

United States1 site, 1 recruiting
  • Methodist Richardson Medical Center- Clinical Research Institute

    Richardson, Texas, 75082

    Colette Ngo Ndjom, 214-947-1289, ClinicalResearch@mhd.com

    Rohan Jeyarajah

    Recruiting

Other trials in United States

About this study

Official title: Psychosocial Burden and Quality of Life in Caretakers of Hepatobiliary Cancer Patients: A Survey-Based Analysis

Assess caregiver psychosocial burden, including Quality of Life, health, interpersonal relationship, access to support, and explore associated sociodemographic and contextual factors.

Read the detailed description

While literature suggests significant psychosocial burden among hepatobiliary cancer caregivers, quantitative data specific to this population remain sparse, particularly regarding their Quality of Life, health, interpersonal relationship, and access to support. This investigation will fill a critical research gap by candidly assessing these dimensions and laying groundwork for future interventions tailored to improve caregiver well-being.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quality of Life score

    Quality of Life score from the World Health Organization Quality of Life Survey

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jun 2026
  2. Study start26 May 2026
  3. Primary completionMay 2027 (estimated)
  4. Study completionMay 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07644091
Sponsor's protocol ID
039.HPB.2025.R
Status last verified
Apr 2026
First submitted
8 Jun 2026
Last updated
12 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The results of this research will be disseminated through submission to peer-reviewed scientific journals and presentation at professional conferences within but not limited to the fields of General Surgery, Hepatobiliary Surgery, and Psychiatry. Findings may also be presented at academic meetings. All study results will be reported in aggregate form. No individual participant will be identifiable in any publication, presentation, or report. If qualitative data are included, direct quotations will be de-identified and reviewed to ensure removal of potentially identifying information. Participants will not receive individual results, as the study does not involve clinical testing or diagnostic evaluation. A general summary of study findings may be made available to participants upon request.

Questions about this trial

What is this clinical trial studying?

An observational study of Psychosocial Problem, run by Methodist Health System at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 12 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Crystee Cooper, DHEd (214-947-1280, ClinicalResearch@mhd.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quality of Life score (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT07644091 | AzTrials